Overview
Pseudoprogeria syndrome, also known as Hallermann-Streiff syndrome (HSS) or Hallermann-Streiff-François syndrome, is a rare congenital disorder characterized by a distinctive combination of craniofacial, ocular, dermatological, and skeletal abnormalities that give affected individuals a prematurely aged (progeroid) appearance. The condition is sometimes also referred to as oculomandibulodyscephaly or dyscephalia mandibulo-oculofacialis. Key clinical features include a characteristic bird-like facial appearance (brachycephaly with frontal bossing, a thin pointed nose, and micrognathia or small jaw), bilateral congenital cataracts, microphthalmia (small eyes), dental anomalies (such as natal teeth, supernumerary teeth, or hypodontia), proportionate short stature, and hypotrichosis (sparse hair), particularly of the scalp, eyebrows, and eyelashes. Skin atrophy, especially over the nose and scalp, contributes to the aged appearance. Additional features may include upper airway obstruction related to the mandibular hypoplasia, which can cause significant respiratory difficulties, particularly in infancy. Intellectual development is typically normal, though some patients may have mild intellectual disability. There is no specific cure or targeted therapy for pseudoprogeria syndrome. Management is multidisciplinary and symptomatic, focusing on ophthalmologic care (including early cataract surgery), dental management, monitoring and treatment of airway obstruction (which may require tracheostomy in severe cases), and orthopedic surveillance. Nutritional support may be needed in infancy due to feeding difficulties associated with the small jaw. Genetic counseling is recommended for affected families, though the exact genetic basis remains incompletely understood in most cases.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Pseudoprogeria syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pseudoprogeria syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Pseudoprogeria syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pseudoprogeria syndrome.
Community
No community posts yet. Be the first to share your experience with Pseudoprogeria syndrome.
Start the conversation →Latest news about Pseudoprogeria syndrome
No recent news articles for Pseudoprogeria syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pseudoprogeria syndrome
What is Pseudoprogeria syndrome?
Pseudoprogeria syndrome, also known as Hallermann-Streiff syndrome (HSS) or Hallermann-Streiff-François syndrome, is a rare congenital disorder characterized by a distinctive combination of craniofacial, ocular, dermatological, and skeletal abnormalities that give affected individuals a prematurely aged (progeroid) appearance. The condition is sometimes also referred to as oculomandibulodyscephaly or dyscephalia mandibulo-oculofacialis. Key clinical features include a characteristic bird-like facial appearance (brachycephaly with frontal bossing, a thin pointed nose, and micrognathia or small
How is Pseudoprogeria syndrome inherited?
Pseudoprogeria syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pseudoprogeria syndrome typically begin?
Typical onset of Pseudoprogeria syndrome is neonatal. Age of onset can vary across affected individuals.